These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. CYLD controls c-MYC expression through the JNK-dependent signaling pathway in hepatocellular carcinoma. Pannem RR; Dorn C; Ahlqvist K; Bosserhoff AK; Hellerbrand C; Massoumi R Carcinogenesis; 2014 Feb; 35(2):461-8. PubMed ID: 24104553 [TBL] [Abstract][Full Text] [Related]
25. Increased midkine gene expression in childhood B-precursor acute lymphoblastic leukemia. Hidaka H; Yagasaki H; Takahashi Y; Hama A; Nishio N; Tanaka M; Yoshida N; Villalobos IB; Wang Y; Xu Y; Horibe K; Chen S; Kadomatsu K; Kojima S Leuk Res; 2007 Aug; 31(8):1045-51. PubMed ID: 17267033 [TBL] [Abstract][Full Text] [Related]
26. A paediatric case of a TdT positive B-cell acute lymphoblastic leukaemia (B-ALL) without Burkitt characteristics. Shende A; Festa RS; Wedgwood JF; Lanzkowsky P Br J Haematol; 1988 Sep; 70(1):129-30. PubMed ID: 3179223 [No Abstract] [Full Text] [Related]
27. Synergistic activity of bortezomib and HDACi in preclinical models of B-cell precursor acute lymphoblastic leukemia via modulation of p53, PI3K/AKT, and NF-κB. Bastian L; Hof J; Pfau M; Fichtner I; Eckert C; Henze G; Prada J; von Stackelberg A; Seeger K; Shalapour S Clin Cancer Res; 2013 Mar; 19(6):1445-57. PubMed ID: 23357978 [TBL] [Abstract][Full Text] [Related]
28. An emerging role of deubiquitinating enzyme cylindromatosis (CYLD) in the tubulointerstitial inflammation of IgA nephropathy. Cui TG; Ichikawa T; Yang M; Dong X; Li J; Cui T Biochem Biophys Res Commun; 2009 Dec; 390(2):307-12. PubMed ID: 19800320 [TBL] [Abstract][Full Text] [Related]
29. ABL1 gene deletion without BCR/ABL1 rearrangement in a young adolescent with precursor B-cell acute lymphoblastic leukemia: clinical study and literature review. Kim MJ; Yoon HS; Lim G; Kim SY; Lee HJ; Suh JT; Lee J; Lee WI; Park TS Cancer Genet Cytogenet; 2010 Jan; 196(2):184-8. PubMed ID: 20082857 [TBL] [Abstract][Full Text] [Related]
30. Reduced expression of CYLD in human colon and hepatocellular carcinomas. Hellerbrand C; Bumes E; Bataille F; Dietmaier W; Massoumi R; Bosserhoff AK Carcinogenesis; 2007 Jan; 28(1):21-7. PubMed ID: 16774947 [TBL] [Abstract][Full Text] [Related]
31. An inactivating CYLD mutation promotes skin tumor progression by conferring enhanced proliferative, survival and angiogenic properties to epidermal cancer cells. Alameda JP; Moreno-Maldonado R; Navarro M; Bravo A; Ramírez A; Page A; Jorcano JL; Fernández-Aceñero MJ; Casanova ML Oncogene; 2010 Dec; 29(50):6522-32. PubMed ID: 20838385 [TBL] [Abstract][Full Text] [Related]
32. Loss of Smad3 in acute T-cell lymphoblastic leukemia. Wolfraim LA; Fernandez TM; Mamura M; Fuller WL; Kumar R; Cole DE; Byfield S; Felici A; Flanders KC; Walz TM; Roberts AB; Aplan PD; Balis FM; Letterio JJ N Engl J Med; 2004 Aug; 351(6):552-9. PubMed ID: 15295048 [TBL] [Abstract][Full Text] [Related]
33. PLAG1 and CYLD do not play a role in the tumorigenesis of adenoid cystic carcinoma. Daa T; Nakamura I; Yada N; Arakane S; Nishida H; Kashima K; Suzuki M; Yokoyama S Mol Med Rep; 2013 Apr; 7(4):1086-90. PubMed ID: 23404581 [TBL] [Abstract][Full Text] [Related]
34. Cylindromatosis and the CYLD gene: new lessons on the molecular principles of epithelial growth control. Massoumi R; Paus R Bioessays; 2007 Dec; 29(12):1203-14. PubMed ID: 18008375 [TBL] [Abstract][Full Text] [Related]
35. A novel missense mutation of the CYLD gene identified in a Hungarian family with Brooke-Spiegler syndrome. Nagy N; Farkas K; Kinyo A; Nemeth IB; Kis E; Varga J; Bata-Csorgo Z; Kemeny L; Szell M Exp Dermatol; 2012 Dec; 21(12):967-9. PubMed ID: 23171463 [TBL] [Abstract][Full Text] [Related]